Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Angiotensin II versus noradrenaline for prevention of acute kidney injury after cardiac surgery
ACTRN12621000195853Phase 3Completed
- Sponsor
- Austin Health
- Start
- Mar 2021
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in acute kidney failure (AKF) comparing Angiotensin II infusion with Noradrenaline infusion (2 arms). Primary endpoints: Duration of study drug infusion as a percentage of total time, Percentage of patients approached who consent to the study and 1 more. Started Mar 2021; status: completed.
02
Drugs
Angiotensin IInorepinephrine
03
Conditions
acute kidney failure (AKF)
Beyond the preview
Go deeper on ACTRN12621000195853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621000195853.